Cartron, G.
95  results:
Search for persons X
?
 
?
6

A phase 1/2, open-label, multicenter study of isatuximab in..:

Carlo-Stella, C ; Zinzani, P.L ; Sureda, A...
https://cris.maastrichtuniversity.nl/en/publications/5d163f18-ed7b-45ef-b334-d47a337fea84.  , 2023
 
?
8

A real-world comparison of tisagenlecleucel and axicabtagen..:

Bachy, E ; Le Gouill, S ; Di Blasi, R...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-022-01969-y.  , 2022
 
?
9

Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxali..:

Houot, R ; Poeschel, V ; Altmann, B...
info:eu-repo/semantics/altIdentifier/doi/10.1097/HS9.0000000000000672.  , 2022
 
?
10

A real-world comparison of tisagenlecleucel and axicabtagen..:

Bachy, E ; Le Gouill, S ; Di Blasi, R...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-022-01969-y.  , 2022
 
?
 
?
14

Integrative analysis of a phase 2 trial combining lenalidom..:

Lemonnier, F ; Safar, V ; Beldi-Ferchiou, A...
info:eu-repo/semantics/altIdentifier/doi/10.1182/bloodadvances.2020003081.  , 2021
 
1-15